ms-anne-trimmer-ceo-medical-technology-association-of-australia-mtaa-australia

Aus Medtech association: Reimbursements remain constrained...

  • Australia
  • |
  • Influencers
  • |
  • By Saptarshi Chaudhuri
  • |
  • 0 Comment

The Medical Technology Association of Australia (MTAA) is the national association of Australia representing companies in the medical technology industry. MTAA aims... Read more

good-news-for-clostridium-difficileinfected-patients-australian-therapeutic-goods-administration-tga-approves-dificid-fidaxomicin

Australian TGA nod for superbug antibiotic

  • Australia
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: An effective new antibiotic designed to specifically treat Clostridium difficile-associated diarrhoea will be available to patients in Australia from... Read more

good-news-for-ischemia-patients-phylogica-gets-european-patent-for-its-peptide-inhibitors-that-target-the-ap-1-pathway

EU patent for Phylomer ischemia peptides

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Phylogica has been granted a new European patent (no. 1793841) entitled: ‘Peptide inhibitors of c-Jun dimerization and uses thereof'. This international... Read more

lonza-manufactures-bionomics-anti-cancer-stem-cell-candidate-bnc101

Lonza produces Bionomics’ stem cell cancer drug

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Bionomics has initiated manufacturing activities for BNC101, its lead anti-cancer stem cell candidate following completion of key preclinical studies.... Read more

cpr-pharma-s-access2asia-service-will-provide-access-to-phase-i-units-and-to-various-ethnicities-in-apac

CPR to provide access to phase I units in APAC

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australian-based CRO, CPR Pharma Services, is launching a service aimed at US-based companies who want access to the Asia Pacific region. While access... Read more

patrys-will-start-recruiting-for-the-third-patient-group-for-its-pat-sm6-multiple-myeloma-trial

Patrys gets nod to continue myeloma trial

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Patrys received approval to progress its phase I/IIa PAT-SM6 multiple myeloma trial based on safety data from its second group of patients. The second... Read more

astrazeneca-alchemia-sign-usd240-mn-drug-deal

AstraZeneca, Alchemia sign $240 mn drug deal

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Alchemia signed a multi-target, drug discovery collaboration with AstraZeneca. The collaboration includes the use of the proprietary Diversity Scanning... Read more

dsm-pharma-decimmune-sign-antibody-deal

DSM Pharma, DecImmune sign antibody deal

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australia's DSM Pharmaceutical, the custom manufacturing and technology business of Royal DSM, has signed an agreement with venture capital funded DecImmune... Read more

sanofi-aventis-is-in-trouble-australian-government-joins-hands-with-generic-drug-maker-apotex-to-sue-sanofi

Aus Govt, Apotex sue Sanofi for extending patent

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The Australian government has joined hands with generics manufacturer Apotex in suing Sanofi Aventis seeking millions in compensation for delaying the... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X